The following article was featured in:
Source:
The Harvard Crimson | Section | News
04/03/2025.
Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon expected to pull back from the biotech industry, representing a blow to a primary...
Continue on to full article...
